Divi's Laboratories Limited (NSE:DIVISLAB) Investors Are Less Pessimistic Than Expected
Apr 10
Have your own idea? Try our Stock Screener
Indian (NIFTY) Healthcare Sector Analysis
UpdatedApr 23, 2025
DataAggregated Company Financials
Companies294
- 7D2.2%
- 3M-1.3%
- 1Y20.0%
- YTD-7.4%
Over the last 7 days, the Healthcare industry has risen 2.2%, driven by gains from Sun Pharmaceutical Industries of 5.7%. In the last 12 months, the industry was up 20%. As for the next few years, earnings are expected to grow by 19% per annum.
Sector Valuation and Performance
Has the Indian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 23 Apr 2025 | ₹28.4t | ₹5.2t | ₹680.2b | 33.9x | 41.8x | 5.5x |
| Fri, 21 Mar 2025 | ₹28.0t | ₹5.2t | ₹680.1b | 31.4x | 41.1x | 5.4x |
| Sun, 16 Feb 2025 | ₹26.9t | ₹5.2t | ₹681.5b | 31.8x | 39.5x | 5.2x |
| Tue, 14 Jan 2025 | ₹28.4t | ₹5.0t | ₹648.1b | 37.6x | 43.8x | 5.6x |
| Thu, 12 Dec 2024 | ₹29.2t | ₹5.0t | ₹643.1b | 38x | 45.3x | 5.8x |
| Sat, 09 Nov 2024 | ₹28.9t | ₹5.0t | ₹625.9b | 40.9x | 46.2x | 5.8x |
| Mon, 07 Oct 2024 | ₹28.9t | ₹4.9t | ₹605.3b | 43.1x | 47.8x | 5.9x |
| Wed, 04 Sep 2024 | ₹28.5t | ₹4.9t | ₹605.1b | 40.7x | 47.1x | 5.9x |
| Fri, 02 Aug 2024 | ₹26.8t | ₹4.7t | ₹564.4b | 38.7x | 47.4x | 5.6x |
| Sun, 30 Jun 2024 | ₹24.1t | ₹4.6t | ₹548.6b | 36x | 44x | 5.2x |
| Tue, 28 May 2024 | ₹23.2t | ₹4.7t | ₹544.9b | 34.4x | 42.6x | 4.9x |
| Thu, 25 Apr 2024 | ₹22.8t | ₹4.6t | ₹512.8b | 35.4x | 44.5x | 5x |
| Sat, 23 Mar 2024 | ₹22.5t | ₹4.6t | ₹512.5b | 33.5x | 43.8x | 4.9x |
| Mon, 19 Feb 2024 | ₹23.1t | ₹4.6t | ₹511.9b | 35.9x | 45.2x | 5x |
| Wed, 17 Jan 2024 | ₹21.3t | ₹4.4t | ₹477.0b | 36.9x | 44.6x | 4.8x |
| Fri, 15 Dec 2023 | ₹19.6t | ₹4.4t | ₹476.2b | 32.9x | 41.2x | 4.4x |
| Sun, 12 Nov 2023 | ₹18.7t | ₹4.4t | ₹474.4b | 32x | 39.4x | 4.3x |
| Tue, 10 Oct 2023 | ₹18.0t | ₹4.3t | ₹452.1b | 32.3x | 39.8x | 4.2x |
| Thu, 07 Sep 2023 | ₹18.1t | ₹4.2t | ₹450.8b | 32.5x | 40.2x | 4.3x |
| Sat, 05 Aug 2023 | ₹17.7t | ₹4.1t | ₹438.8b | 31.4x | 40.4x | 4.3x |
| Mon, 03 Jul 2023 | ₹16.4t | ₹4.1t | ₹425.6b | 28.6x | 38.5x | 4x |
| Wed, 31 May 2023 | ₹14.9t | ₹4.1t | ₹432.7b | 27.6x | 34.3x | 3.6x |
| Fri, 28 Apr 2023 | ₹13.9t | ₹3.9t | ₹373.3b | 26.6x | 37.1x | 3.6x |
| Sun, 26 Mar 2023 | ₹13.0t | ₹3.9t | ₹372.9b | 24.6x | 35x | 3.4x |
| Tue, 21 Feb 2023 | ₹13.4t | ₹3.9t | ₹373.2b | 26.1x | 35.8x | 3.5x |
| Thu, 19 Jan 2023 | ₹14.0t | ₹3.7t | ₹377.7b | 29.2x | 37x | 3.7x |
| Sat, 17 Dec 2022 | ₹13.9t | ₹3.7t | ₹377.3b | 29x | 36.9x | 3.8x |
| Mon, 14 Nov 2022 | ₹14.1t | ₹3.7t | ₹375.8b | 26.9x | 37.6x | 3.8x |
| Wed, 12 Oct 2022 | ₹13.7t | ₹3.6t | ₹359.9b | 25.5x | 38.1x | 3.8x |
| Fri, 09 Sep 2022 | ₹13.7t | ₹3.6t | ₹361.6b | 26x | 38x | 3.8x |
| Sun, 07 Aug 2022 | ₹13.8t | ₹3.6t | ₹371.6b | 23.2x | 37x | 3.9x |
| Tue, 05 Jul 2022 | ₹13.0t | ₹3.5t | ₹376.5b | 22.2x | 34.5x | 3.7x |
| Thu, 02 Jun 2022 | ₹13.0t | ₹3.5t | ₹376.7b | 22.7x | 34.4x | 3.7x |
| Sat, 30 Apr 2022 | ₹14.2t | ₹3.4t | ₹420.5b | 25x | 33.9x | 4.2x |
Price to Earnings Ratio
33.9x
Current Industry PE
- Investors are relatively neutral on the Indian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 40.5x.
- The 3-year average PS ratio of 4.5x is lower than the industry's current PS ratio of 5.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 17% per year over the last three years.
- Revenues for these companies have grown 15% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare sector?
| IN Market | 3.57% | |
| Healthcare | 2.16% | |
| Medical Equipment | 8.09% | |
| Healthcare Services | 2.95% | |
| Biotech | 2.12% | |
| Pharma | 1.98% | |
| Life Sciences | 1.48% | |
| Healthtech | 0.26% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 62.3x.
- Analysts are expecting annual earnings growth of 21.2%, which is lower than the prior year's growth of 49.4% per year.
- Investors are most pessimistic about the Pharma industry, which is trading close to its 3-year average of 37.0x.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 31% over the next 5 years.
- This is better than its past earnings growth rate of 13% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 17% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries | ₹1.79k | 5.7% +₹229.6b | 20.4% | PE37.5x | |
| 500257 Lupin | ₹2.09k | 7.9% +₹69.9b | 32.2% | PE33.2x | |
| AUROPHARMA Aurobindo Pharma | ₹1.25k | 10.0% +₹65.9b | 15.0% | PE20.7x | |
| 543220 Max Healthcare Institute | ₹1.13k | 4.9% +₹51.3b | 39.0% | PE108.9x | |
| ZYDUSLIFE Zydus Lifesciences | ₹868.00 | 5.6% +₹46.2b | -7.0% | PE19.3x |
